A. Naghipour et al. / Journal of Organometallic Chemistry 689 (2004) 2494–2502
2497
C28H42B2P2 (Mr =462.21): C, 72.76; H, 9.16. Found: C,
72.78; H, 9.06%.
2.9. Synthesis of Pri2P(H)BH3 (8)
LiAlH4 (10 mmol, 10 ml of 1 M/l ether solution) and
BH3 ÆSMe2 (1.14 ml, 12 mmol) were added consecutively
by syringe to a stirred solution of ClPPri2 (1.526 g, 1.59
ml, 10 mmol) in THF (40 ml) at 0 ꢁC. After warming to
room temperature and stirring for 2 h, the reaction mix-
ture was treated with HCl (5 ml), ice ca. 12 g and
CH2Cl2 (20 ml). The organic layer was separated, and
the aqueous layer extracted twice with CH2Cl2 (2·10
ml). The combined extracts were dried over MgSO4
and then the solvent evaporated under vacuum to afford
pure diisopropylphosphine-borane adduct as a colorless
liquid. 1H NMR (300 MHz, CDCl3): d 0.46 (br, q,
JHP =93.45 Hz, 3H, BH3), 1.30 (m, 12H, (CH3)2CH),
2.17 (m, 2H, (CH3)2CH), 4.22 (m, JHP =350.82 Hz,
1H, PH). 13C{1H} NMR (75 MHz, CDCl3): d 18.16
(d, J=138.82 Hz), 19.43 (d, J=34.46 Hz). 31P{1H}
NMR (121 MHz, CDCl3): d 28.01 (br, q, m). Anal. Calc.
for C6H18BP (Mr =131.995): C, 54.60; H, 13.75. Found:
C, 54.75; H, 13.72%.
2.7. Synthesis of {C6H4-1-(CH2But2)-3-(CH2PPh2)}
(7)
HBF4 ÆEt2O complex, 85% (5.54 ml, 32 mmol) was
added via syringe to a stirred solution of 6 (1.489g, 3.2
mmol) in 30 ml of CH2Cl2 at ꢀ5 ꢁC. The mixture was al-
lowed to reach room temperature and stirred overnight.
After the prescribed reaction time, 60 ml of ether and 160
ml of a degassed saturated aqueous solution of NaHCO3
were added with vigorous stirring for 10 min. The organ-
ic layer was separated and the aqueous layer extracted
with ether. The combined organic extracts were washed
with water, brine and dried over MgSO4. After filtration,
the solution was passed through a short plug of celite and
the solvent evaporated under vacuum to afford 7 as col-
orless oil (1.25 g, 2.87 mmol, 90%). 1H NMR (300 MHz,
3
benzene-d6): d 0.769 (d, JHP =10.50 Hz, (CH3)3C, 2.38
2
(d, JPH =1.80 Hz, 2H, CH2PBut2), 2.99 (s, 2H,
CH2PPh2), 6.58–7.44 (m, 14H, Ar). 13C{1H} NMR (75
MHz, benzene-d6): d 28.83 (d, J=25.64 Hz, (CH3)3C,
29.84 (d, J=13.20 Hz, (CH3)3C, 31.61 (d, J=24.13 Hz,
CH2PBut2), 36.16 (d, J=16.06 Hz, CH2PPh2), 126.82
(d, J=7.24 Hz), 128.49, 128.63 (d, J=4.00 Hz), 131.25,
131.37, 131.95, 133.30 (d, J=18.40 Hz), 137.63 (d,
J=8.10 Hz), 139.20 (d, J=16.60 Hz), 141.93 (d,
J=12.00 Hz). 31P{1H} NMR (121 MHz, benzene-d6): d
ꢀ9.39 (PPh2), 33.87 (PBut2).
2.10. Synthesis of {C6H4-1-(CH2PPh2(BH3))-3-(CH2-
PPri2(BH3))} (9)
To a stirred solution of phosphine 8 (0.412 g, 3.12
mmol) in THF (30 ml) was added slowly a 1.6 M solu-
tion of n-BuLi in hexane (1.95 ml, 3.12 mmol) at ꢀ78
ꢁC (dry ice–acetone bath). The reaction mixture was al-
lowed to reach room temperature to afford a colorless
mixture. The dry ice–acetone bath is replaced and a so-
lution of 5 (1.097 g, 3.12 mmol) in THF (20 ml) added
drop wise by syringe over a period of 30 min. The tem-
perature was allowed to reach room temperature over a
period of 3 h and kept at this temperature for further 2
h. The reaction mixture was quenched by adding an
aqueous solution of NH4Cl (wt 10%, 30 ml). The prod-
uct was extracted with CH2Cl2 and the combined ex-
tracts dried over MgSO4. The solvent was removed
under reduced pressure and the solid residue subjected
to column chromatography using silica gel as a solid
support and eluted with CH2Cl2/hexane (1.15:1) to af-
2.8. Synthesis of [PdCl{C6H3-2-(CH2PPh2)-6-(CH2-
PBut2)} (11)
To a stirred suspension of [PdCl2(COD)] (0.819 g,
2.87 mmol) in toluene (30 ml) a solution of ligand 7
(1.250 g, 2.87 mmol) in toluene (30 ml) was slowly add-
ed. The resulting solution was set to reflux for 5 h. After
this time, the solution was filtered over a cotton pad and
pumped off under vacuum to dryness. The crude solid
was purified by recrystallization from CHCl3/MeOH
to afford complex 11 as white crystals (1.24 g, 2.15
1
1
mmol, 75%): H NMR (300 MHz, CDCl3): d 1.37 (d,
ford 9 as a white solid (1.259 g, 2.90 mmol, 93%). H
2
3JPH =13.49 Hz, CH3, 18H), 3.23 (d, JPH =9.3 Hz,
NMR (300 MHz, CDCl3): d 0.30 (br, m, 6H, BH3),
1.01 (m, 12H, (CH3)2CH), 1.85 (m, 2H, (CH3)2CH),
2.84 (d, JHP =11.10 Hz, CH2PPri2), 3.53 (d, JHP =12.29
Hz, CH2PPh2), 6.73–7.07 (m, 4H, Ar), 7.34–7.60 (m,
10H, Ar). 13C{1H} NMR (75 MHz, CDCl3): d 16.97
(d, J=10.33 Hz, (CH3)2CH, 21.41 (d, J=32.12 Hz,
(CH3)2CH), 27.92 (d, J=27.52, CH2PPri2), 33.76 (d,
J=32.12 Hz, CH2PPh2), 128.18, 128.27, 128.63,
128.76, 128.99, 131.30, 131.39, 132.21, 132.51 (d,
J=8.60 Hz), 133.52. 31P{1H} NMR (121 MHz, CDCl3):
d 18.88 (Ph2PBH3), 35.10 (Pri2PBH3). Anal. Calc. for
C26H38B2P2 (Mr =434.16): C, 71.93; H, 8.82. Found:
C, 72.10; H, 8.75%.
2
2H, CH2PBut2), 3.84 (d, JPH =10.80 Hz, 2H,
CH2PPh2), 6.88–7.18 (m, 3H, Ar), 7.29–7.83 (m, 10H,
Ar). 13C{1H} NMR (300 MHz, CDCl3): d 29.34 (d,
J=3.5 Hz, CH3), 34.33 (dd, J=23.53 Hz, J=2.3 Hz),
35.23 (dd, J=12.1 Hz, J=3 Hz), 42.27 (d, J=3.1 Hz),
122.40, 122.58, 122.67, 122.89, 125.34, 128.60 (d,
J=9.73 Hz), 130.31, 133.00 (d, J=11.46 Hz), 147.90
(d, J=23.00 Hz), 151.30 (d, J=18.93 Hz). 31P{1H}
2
NMR (121 MHz, CDCl3): d 31.62 (d, JPP =394 Hz,
2
PPh2), 78.14 (d, JPP =394 Hz, PBut2). Anal. Calc. for
C28H35ClP2Pd (Mr =575.388): C, 58.45; H, 6.13. Found:
C, 58.40; H, 6.13%.